Rimonabant weight loss drug went on sale for the first time in Great Britain in 2006 and since then, it has become extremely popular among overweight Europeans. Rimonabant and Rimonabant generic names – Acomplia (in Europe) and Zimulti (in the USA) belong to a new class of therapeutic agents, called Cannabinoid-1 Receptor Blockers (CB1).
Except these anti-obesity medications, you may find on world pharmaceutical markets such Rimonabant generic versions as Rimonabent, Rimoslim, Riobant and Slimona.
It is believed that Rimonabant reduces the activity of endocannabinoid system, which plays an important role in regulation of the body mass and energy balance in the human body
Rimonabant 20 mg drug is meant for the reduction of many risk factors, associated with cardiovascular and metabolic illnesses in overweight patients. Rimonabant and its generic versions are recommended for anti-obesity treatment of patients, who cannot use any other appetite suppressant for some reason.
When using Rimonabant generic drug, doctors have to monitor patients’ mood changes, since this drug can cause depressive state and suicidal thoughts.
Because of this, at the beginning of 2009, Rimonabant and Rimonabant generic drug were officially withdrawn by the European Medicines Agency from European market. Earlier, in 2007, the FDA’s Endocrine and Metabolic Drugs Advisory Committee recommended to avoid using Zimulti to treat overweight.
In addition, according to clinical trials, apart from anxiety and insomnia, about 25% of patients using Rimonabant generic drugs experienced a sharp rise in aggression. Moreover, Rimonabant generic drugs increased the risk of suicidal thoughts and depression.
However, despite the banning, Rimonabant and its generic versions are still available on different online pharmacies. Many obese patients are ready to do anything to become slim, even to buy Rimonabant generic drug from dubious sellers.
Various supplements that are safe for a patient’s health can be a good alternative to anti-obesity treatment by means of Rimonabant drug.